{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:06:40Z","timestamp":1747973200669,"version":"3.41.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>F\u00fcr die Diagnosestellung, Therapie und Verlaufsbeurteilung von Kopfschmerzerkrankungen m\u00fcssen in der Anamnese zahlreiche Informationen erfragt werden. Dies wird wesentlich erleichtert, wenn die Patient:innen diese Informationen bereits vorab anhand eines Fragebogens zusammenstellen. Expert:innen der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft (DMKG) haben daf\u00fcr den DMKG-Kopfschmerzfragebogen entwickelt, der sowohl kopfschmerzspezifische Informationen (H\u00e4ufigkeit, Charakteristika, Begleitsymptome, Medikation) als auch Begleiterkrankungen erfasst und dar\u00fcber hinaus validierte Skalen zu psychischen Begleitfaktoren, Beeintr\u00e4chtigung und Lebensqualit\u00e4t enth\u00e4lt. Es gibt separate Versionen f\u00fcr Erst- und Wiedervorstellung sowie ein Clusterkopfschmerzmodul. Der DMKG-Kopfschmerzfragebogen ist f\u00fcr Fachkreise nach Registrierung online frei erh\u00e4ltlich (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.dmkg.de\/dmkg-kopfschmerzfragebogen\" ext-link-type=\"uri\">https:\/\/www.dmkg.de\/dmkg-kopfschmerzfragebogen<\/jats:ext-link>) und steht zum Ausdrucken oder als ausf\u00fcllbares PDF zur Verf\u00fcgung. Er kann mit dem enthaltenen PDF-Kopfschmerzkalender oder mit der DMKG-App als elektronischer Kopfschmerzkalender kombiniert werden. Eine digitale Version ist geplant. Der DMKG-Kopfschmerzfragebogen ist ein wichtiger Baustein zur Qualit\u00e4tssicherung der Kopfschmerzversorgung in Deutschland.<\/jats:p>","DOI":"10.1007\/s00482-025-00870-0","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:49:14Z","timestamp":1739476154000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Der DMKG-Kopfschmerzfragebogen","The headache questionnaire of the German Migraine and Headache Society (DMKG)"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9510-7158","authenticated-orcid":false,"given":"Ruth","family":"Ruscheweyh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charly","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Dresler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Patrick J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Neeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Ruschil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Go\u00dfrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10072-005-0416-7","volume":"2","author":"F Andrasik","year":"2005","unstructured":"Andrasik\u00a0F, Flor\u00a0H, Turk\u00a0DC (2005) An expanded view of psychological aspects in head pain: the biopsychosocial model. Neurol Sci Suppl 2:s87\u2013s91. https:\/\/doi.org\/10.1007\/s10072-005-0416-7","journal-title":"Neurol Sci"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10194-022-01471-3","volume":"23","author":"C Rosignoli","year":"2022","unstructured":"Rosignoli\u00a0C, Ornello\u00a0R, Onofri\u00a0A et\u00a0al (2022) Applying a\u00a0biopsychosocial model to migraine: rationale and clinical implications. J\u00a0Headache Pain 23:100. https:\/\/doi.org\/10.1186\/s10194-022-01471-3","journal-title":"J Headache Pain"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00278-024-00726-5","volume":"69","author":"T Klan","year":"2024","unstructured":"Klan\u00a0T, Diezemann-Pr\u00f6\u00dfdorf\u00a0A, Guth\u00a0A\u2011L et\u00a0al (2024) Verhaltenstherapeutische Diagnostik und Therapie bei Kopfschmerzerkrankungen. Psychotherapie 69:237\u2013247. https:\/\/doi.org\/10.1007\/s00278-024-00726-5","journal-title":"Psychotherapie"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/wnl.53.5.988","volume":"53","author":"WF Stewart","year":"1999","unstructured":"Stewart\u00a0WF, Lipton\u00a0RB, Whyte\u00a0J et\u00a0al (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988\u2013994. https:\/\/doi.org\/10.1212\/wnl.53.5.988","journal-title":"Neurology"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00482-015-0019-z","volume":"29","author":"P Nilges","year":"2015","unstructured":"Nilges\u00a0P, Essau\u00a0C (2015) Depression, anxiety and stress scales: DASS\u2014A screening procedure not only for pain patients. Schmerz 29:649\u2013657. https:\/\/doi.org\/10.1007\/s00482-015-0019-z","journal-title":"Schmerz"},{"key":"870_CR6","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society The International Classification of Headache Disorders, 3. Aufl. Cephalalgia, 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-022-01406-y","volume":"23","author":"K Kamm","year":"2022","unstructured":"Kamm\u00a0K, Straube\u00a0A, Ruscheweyh\u00a0R (2022) Cluster Headache Impact Questionnaire (CHIQ)\u2014a\u00a0short measure of cluster headache related disability. J\u00a0Headache Pain 23:37. https:\/\/doi.org\/10.1186\/s10194-022-01406-y","journal-title":"J Headache Pain"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-022-01447-3","volume":"23","author":"R Ruscheweyh","year":"2022","unstructured":"Ruscheweyh\u00a0R, Klonowki\u00a0T, Go\u00dfrau\u00a0G et\u00a0al (2022) The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients. J Headache Pain 23:74. https:\/\/doi.org\/10.1186\/s10194-022-01447-3","journal-title":"J Headache Pain"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"333102423117485","DOI":"10.1177\/03331024231174855","volume":"43","author":"R Ruscheweyh","year":"2023","unstructured":"Ruscheweyh\u00a0R, Dresler\u00a0T, F\u00f6rderreuther\u00a0S et\u00a0al (2023) What do patients\u2019 efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry. Cephalalgia 43:3331024231174855. https:\/\/doi.org\/10.1177\/03331024231174855","journal-title":"Cephalalgia"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s10194-023-01676-0","volume":"24","author":"R Ruscheweyh","year":"2023","unstructured":"Ruscheweyh\u00a0R, Gossrau\u00a0G, Dresler\u00a0T et\u00a0al (2023) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry. J\u00a0Headache Pain 24:135. https:\/\/doi.org\/10.1186\/s10194-023-01676-0","journal-title":"J Headache Pain"},{"key":"870_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241261077","author":"R Ruscheweyh","year":"2024","unstructured":"Ruscheweyh\u00a0R, F\u00f6rderreuther\u00a0S, Freilinger\u00a0T et\u00a0al (2024) Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry. Cephalalgia 44:3331024241261077. https:\/\/doi.org\/10.1177\/03331024241261077","journal-title":"Cephalalgia"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00482-002-0162-1","volume":"16","author":"B Nagel","year":"2002","unstructured":"Nagel\u00a0B, Gerbershagen\u00a0HU, Lindena\u00a0G, Pfingsten\u00a0M (2002) Entwicklung und empirische \u00dcberpr\u00fcfung des Deutschen Schmerzfragebogens der DGSS. Schmerz 16:263\u2013270. https:\/\/doi.org\/10.1007\/s00482-002-0162-1","journal-title":"Schmerz"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42466-022-00200-0","volume":"4","author":"H-C Diener","year":"2022","unstructured":"Diener\u00a0H\u2011C, Kropp\u00a0P, Dresler\u00a0T et\u00a0al (2022) Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline. Neurol Res Pract 4:37. https:\/\/doi.org\/10.1186\/s42466-022-00200-0","journal-title":"Neurol Res Pract"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00482-017-0214-1","volume":"31","author":"P Kropp","year":"2017","unstructured":"Kropp\u00a0P, Meyer\u00a0B, Dresler\u00a0T et\u00a0al (2017) Relaxation techniques and behavioural therapy for the treatment of migraine: Guidelines from the German Migraine and Headache Society. Schmerz 31:433\u2013447. https:\/\/doi.org\/10.1007\/s00482-017-0214-1","journal-title":"Schmerz"},{"key":"870_CR15","unstructured":"Diener H\u2011C, F\u00f6rderreuther S (2022) Therapie der Migr\u00e4neattacke und Prophylaxe der Migr\u00e4ne, S1-Leitlinie, 2022, DGN und DMKG. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/030-057"},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s004820050216","volume":"13","author":"H-D Basler","year":"1999","unstructured":"Basler\u00a0H\u2011D (1999) Marburger Fragebogen zum habituellen Wohlbefinden. Schmerz 13:385\u2013391. https:\/\/doi.org\/10.1007\/s004820050216","journal-title":"Schmerz"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-025-00870-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-025-00870-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-025-00870-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:47:10Z","timestamp":1747903630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-025-00870-0"}},"subtitle":["Ein neues Tool der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft zur Verbesserung der Kopfschmerzversorgung","A\u00a0new tool to improve headache care"],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s00482-025-00870-0","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"16 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Ruscheweyh: Vortragshonorare, Beratert\u00e4tigkeit, Unterst\u00fctzung f\u00fcr Kongressreisen: Novartis, Lilly, Lundbeck, AbbVie, Pfizer, Novartis, Teva. Forschungsf\u00f6rderung: DFG. Ehrenamtlich kooptiertes Pr\u00e4sidiumsmitglied der DMKG. C.\u00a0Gaul: AbbVie-Allergan Pharma, TEVA-Ratiopharm, Lilly, Novartis Pharma, Hormosan Pharma, Vectura Fertin Pharma, Sanofi, Reckitt-Benckiser, Lundbeck, Perfood und Gr\u00fcnenthal; Forschungsf\u00f6rderung: DFG. Ehrenamtlich Generalsekret\u00e4r der DMKG bis Ende 2023. T.\u00a0Dresler: Vortragshonorare, Beratert\u00e4tigkeit: Novartis, Teva, Hormosan. Ehrenamtlich kooptiertes Pr\u00e4sidiumsmitglied der DMKG. T.\u00a0Patrick J\u00fcrgens: Forschungsf\u00f6rderung durch Novartis, Gemeinsamer Bundesausschuss, EFRE. Honorar f\u00fcr Vortr\u00e4ge und\/oder Teilnahme an Advisory Boards: AbbVie, Allergan, Betapharm. Chordate, Gr\u00fcnenthal, Hormosan, Lilly, Lundbeck, Novartis, Pfizer, Sanofi und TEVA. Autorenhonorare von Elsevier. Ehrenamtlich Vizepr\u00e4sident der DMKG. D.\u00a0Lewis: Vortragshonorare, Beratert\u00e4tigkeit: Allergan Pharma, Hormosan Pharma, Lilly, Lundbeck, Novartis Pharma und TEVA-Ratiopharm. Ehrenamtlich Schatzmeister der DMKG. T.\u00a0Kraya: Vortrags- oder Beratert\u00e4tigkeit: Allergan Pharma, Hormosan Pharma, Gr\u00fcnenthal, Lilly, Novartis, Teva. Forschungsf\u00f6rderung: DFG, Innovationsfonds, BMBF, Allergan Pharma, Hormosan Pharma, Gr\u00fcnenthal, Lilly, Novartis, Teva, Alexion und Argenx. Ehrenamtlich\u00a02. Vizepr\u00e4sident DMKG. L.\u00a0Neeb: Vortragshonorare, Beratert\u00e4tigkeit: Lilly, Novartis, TEVA, AbbVie, Lundbeck, Perfood. Forschungsf\u00f6rderung: DLR, TEVA, Lilly. Ehrenamtlich Pr\u00e4sident der DMKG. V.\u00a0Ruschil: Vortragshonorar: TEVA. Forschungsf\u00f6rderung: Novartis. Ehrenamtlich kooptiertes Pr\u00e4sidiumsmitglied der DMKG. G.\u00a0Go\u00dfrau: Vortragshonorare, Beratert\u00e4tigkeit: Teva, Novartis, Sanofi, Lundbeck, IMPP. Forschungsf\u00f6rderung: DFG, MSD, Novartis, Kosing-Stiftung, TU Dresden. Ehrenamtlich Generalsekret\u00e4rin der DMKG.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}